Tag: Department of Health and Social Care

  • PRESS RELEASE : New plan to make it easier for patients to see their GP [May 2023]

    PRESS RELEASE : New plan to make it easier for patients to see their GP [May 2023]

    The press release issued by the Department for Health and Social Care on 8 May 2023.

    Action to make it easier for patients to contact their GP and end the 8am rush, with £240 million given to practices across England to embrace latest technology.

    Patients will be able to contact their general practice more easily and quickly – and find out exactly how their request will be handled on the day they call – as part of a major multi-million pound overhaul of primary care, the government and NHS will announce this week.

    Practices across England will also be given £240 million this year to embrace the latest technology, replacing old analogue phones with modern systems so patients never get engaged tones and easy-to-use online tools to ensure patients get the care they need as soon as possible.

    This will mean that when patients contact their practice online or over the phone they will know on the day they make contact how their query will be managed, rather than being told to call back later. If their need is urgent, they will be assessed and given appointments on the same day. If it is not urgent, appointments should be offered within 2 weeks, or patients will be referred to NHS 111 or a local pharmacy.

    Primary care is the way most people access the NHS and the government is committed to modernising the way patients contact their GP surgeries – improving satisfaction and delivering on the Prime Minister’s promise to cut waiting lists.

    Health and Social Care Secretary, Steve Barclay, will announce a major expansion of the role of receptionists to become expert ‘care navigators’, whose job it is to gather information, to make sure patients are directed to the most suitable healthcare professional and to simplify and streamline the process.

    Health and Social Care Secretary, Steve Barclay, said:

    We are already making real progress with 10% more GP appointments happening every month compared to before the pandemic.

    I want to make sure people receive the right support when they contact their general practice and bring an end to the 8am scramble for appointments.

    To do this we are improving technology and reducing bureaucracy, increasing staffing and changing the way primary care services are provided, which are all helping to deliver on the government’s promise to cut waiting lists.

    Minister for Health, Neil O’Brien, said:

    Where GPs have already moved over to these new technologies we see they free up the phones, making it much easier for people to get through to their general practice team.

    As well as being more convenient for patients, these really easy to use digital tools allow a lot of patients to get the help they need without ever needing to go in for an appointment, which will help cut waiting lists.

    Investing £240 million in these modern tools and the help GPs need to move onto them will make things more convenient for patients, but also make the workload more manageable for general practice teams.

    An average sized practice of 10,000 patients often receives more than 100 calls in the first hour every Monday.

    With advanced digital telephony, rather than an engaged tone, patients will receive a queue position, a call back option and their call can be directly routed to the right professional. The phone system will also be integrated with the clinical systems so practice staff can quickly identify patients and their information from phone numbers.

    Practices that have invested in modern online booking and messaging systems find they help free up phones for those who prefer to call, while giving patients a convenient way to get the help they need.

    As well as helping patients to make contact, the government is supporting staff in dealing with the calls. Working with NHS England the government will fund 6,500 care navigator training places – that is one member of staff per practice who can then pass on the training to colleagues.

    Care navigators will help assess, prioritise, respond and assist. They can help make sure those who want to see a named GP or preferred member of staff can do so while those who are happy to see a duty doctor can also do so.

    Care navigators will direct patients to other professionals within the general practice or other medical professionals such as community pharmacists who can best meet the needs of the patients. Successful care navigation can help direct 40% of requests more effectively and speeds up appointments for those who need them.

    The government will provide primary care networks and GP practices with the funding and support required to make the changes, including through integrated care boards.

    Dr Amanda Doyle, National Director Primary Care and Community Services, NHS England, said:

    Produced by the NHS, this plan will make it easier for patients to access the care they need.

    GPs and their teams are already delivering half a million more appointments a week than before the COVID pandemic.

    However, we know staffing needs to be put on a sustainable footing so we are also working with government to publish a long term workforce plan.

  • PRESS RELEASE : People urged to get Covid jab before offer ends [May 2023]

    PRESS RELEASE : People urged to get Covid jab before offer ends [May 2023]

    The press release issued by the Department of Health and Social Care on 5 May 2023.

    The offer of a first or second dose of Covid vaccine will end on 30 June 2023 for most people.

    • The offer of a first and second dose of Covid vaccine for those at lower risk of severe illness will end on 30 June 2023
    • There are eight weeks left for people who are completely unvaccinated to get their first and second doses
    • Around 40 million adults across England have already come forward for both doses

    People who have not yet come forward for their first and/ or second dose of the Covid vaccine are being encouraged to get their jabs before the offer ends on Friday 30 June.

    The NHS’s world-leading vaccination programme has so far delivered over 146 million Covid jabs, helping to save tens of thousands of lives, protect the most vulnerable from serious illness and allowed us to resume our normal lives without restrictions.

    For people aged 18 and over, there is an 8-week interval requirement between receiving a first and second dose of Covid vaccine. Appointments can be booked easily online, by calling 119, or people can visit one of the hundreds of walk-in vaccination sites open across the country.

    Building on the success of autumn and spring booster programmes, a seasonal, targeted vaccination offer will remain open for those most at risk, in line with advice from the Joint Committee on Vaccination and Immunisation (JCVI). This will help to focus efforts and ensure the most efficient use of NHS resources as we work to cut the backlogs and reduce waiting times.

    Health Minister Maria Caulfield said:

    As we live with Covid without restrictions on our freedoms, it is right that we move towards a more targeted vaccination offer that prioritises those most at risk, so we can focus our efforts on cutting waiting lists for NHS treatment – one of the Prime Minister’s top five priorities.

    As the offer for any adult to get a Covid vaccine comes to an end on 30 June, I would urge those who have not yet come forward to choose to have the first and second Covid vaccine. It takes minutes to get your jab and thousands of sites are open across England.

    Vaccines are our best line of defence against the virus. I’ve stayed up to date with mine – it’s quick and easy so I would urge you to do the same before the offer closes.

    This year’s spring booster programme continues to gather pace, with over two million eligible people receiving their vital top-up dose.  Roving NHS vaccination teams have been visiting care homes across the country since 3 April, with eligible people living in the community accessing the jab since 17 April. The spring campaign will end on 30 June – the same day the offer of a first or second jab ends.

    The JCVI advised the risk of serious illness with Covid continues to be disproportionately greater in those from older age groups, residents in care homes for older adults, and persons with certain underlying health conditions.

    NHS Director of Vaccinations and Screening Steve Russell said:

    The fastest and largest vaccination programme in NHS history has delivered more than 146 million Covid jabs since it began, including more than 45 million first doses, but now it is right as we learn to live with covid, that we move to targeted seasonal campaigns to protect the most vulnerable.

    With the existing offer of a first and second dose for everyone set to end alongside the current spring campaign, everyone aged 18 and over who is unvaccinated must come forward for their primary course by the end of June to receive protection.

    The vaccines are safe, effective, and the best way to boost your protection from serious illness caused by covid – so please do come forward for your dose of protection.

    Dr Mary Ramsay, Head of Immunisation at the UK Health Security Agency, said:

    The Covid vaccines have enabled us to live with the virus thanks to the protection they have given the millions >of people who have come forward to date.

    Getting the vaccine remains the best way to avoid severe illness and it can increase your protection even if you have previously had the virus. It only takes a few minutes and I encourage anyone who has not yet done so to come forward before the offer ends.

    Should a person move into an at-risk group, the offer of a first or second dose will re-open with the seasonal booster programmes.

  • PRESS RELEASE : Negotiations begin for a new medicine pricing scheme [May 2023]

    PRESS RELEASE : Negotiations begin for a new medicine pricing scheme [May 2023]

    The press release issued by the Department of Health and Social Care on 4 May 2023.

    The government, NHS England and the pharmaceutical industry will begin negotiating the successor to the voluntary scheme for branded medicines, pricing and access (VPAS).

    • Negotiations for a new voluntary scheme for branded medicines pricing to open between the government, NHS England and the Association of the British Pharmaceutical Industry (ABPI) today
    • Parties are negotiating an agreement that supports better patient outcomes and a healthier population, a financially sustainable NHS, while also supporting economic growth
    • A new voluntary scheme is expected to take effect from 1 January 2024, replacing the current scheme which ends on 31 December 2023

    Negotiations for the successor to the voluntary scheme for branded medicines, pricing and access (VPAS) will begin today [Thursday 4 May] between the government, NHS England and the pharmaceutical industry.

    For over 65 years the government and the pharmaceutical industry have worked together to help manage the affordability of medicines for the NHS and ensure rapid access and uptake of new medicines for patients, while also supporting the UK’s life sciences sector so that it can continue to deliver new innovations and economic growth.

    In their first meeting, the government, NHS England and industry – represented by the ABPI – are expected to agree to a shared negotiation aim of working toward a mutually beneficial agreement that supports better patient outcomes and a healthier population, a financially sustainable NHS, and UK economic growth.

    The success of the negotiations will be determined through securing a new voluntary scheme that:

    • promotes better patient outcomes and a healthier population, by:
      • securing NHS patients rapid access to new clinically and cost-effective medicines, through streamlined approvals and better commercial and funding arrangements which reward innovation, so that the UK is an internationally competitive location for launching new medicines
      • tackling unwarranted variation in the use, and patient access to, approved medicines across the country
      • encouraging the development of the innovative and cost-effective medicines
    • supports UK economic growth, by:
      • supporting the UK’s life sciences industry to help drive economic growth, particularly through its investment in research and development and clinical research
      • ensuring that the commercial environment for branded medicine suppliers to the NHS helps make the UK an internationally competitive place to invest
      • delivering a net benefit to the UK economy overall
    • contributes to a financially sustainable NHS by:
      • keeping the price of branded medicines affordable for the NHS
      • supporting the NHS and industry to develop sustainable financial and investment strategies
      • delivering value for money for the taxpayer and the NHS by securing resilient provision of safe and effective medicines at reasonable prices, and encouraging efficient competition in medicines supply

    Health Minister, Will Quince, said:

    These negotiations will ensure a new scheme continues to deliver value for money by providing significant savings for our health services, securing access to innovative lifesaving drugs for NHS patients, and helping to reduce waiting times – one of the Prime Minister’s 5 priorities.

    The current voluntary scheme supports investment in NHS services and saves billions of pounds for the NHS, while also promoting innovations and a successful life sciences sector.

    It’s vitally important that the successor to the current scheme delivers for the taxpayer, patients, the NHS, and life sciences.

    Richard Torbett, Chief Executive at the ABPI, said:

    These negotiations provide an opportunity to secure the UK’s place as a global leader in life science research and medical innovation while also ensuring the best outcomes for UK patients and a thriving economy.

    Working together, we can boost UK science and create the conditions for innovative medicines to deliver their true value as an investment in the nation’s health, wealth, and productivity.

    Sir Hugh Taylor, who chaired the Accelerated Access Review in 2014 to bring innovative technologies to the NHS, was appointed last month as Chief Negotiations Advisor for the VPAS scheme.

    Sir Hugh Taylor, said:

    The future voluntary scheme must continue to benefit the NHS and give its patients access to the best medicines, while supporting our life sciences sector.

    I’m looking forward to reaching an agreement which not only benefits the NHS but will also encourage the pharmaceutical sector to continue investing in the UK.

    The current scheme – which came into force in 2019 – is due to expire at the end of 2023. Negotiations are due to conclude in the autumn ahead of the new scheme starting on 1 January 2024.

  • PRESS RELEASE : Record number of doctors and nurses in the NHS helping to cut waiting lists [April 2023]

    PRESS RELEASE : Record number of doctors and nurses in the NHS helping to cut waiting lists [April 2023]

    The press release issued by the Department of Health and Social Care on 27 April 2023.

    There are over 1.27 million full-time equivalent staff working in NHS trusts and commissioning bodies in England.

    • More doctors, nurses and staff than ever before working in the NHS
    • Data also shows 440 more doctors working in general practice and face-to-face appointments on the rise
    • Government on track to deliver on commitments for 50,000 more nurses and 26,000 more primary care staff by 2024

    There are record numbers of doctors and nurses working in the NHS helping to deliver extra appointments, speed up diagnoses and tackle the Covid backlog, according to data published today by NHS England.

    There are over 1.27 million full-time equivalent staff working in NHS trusts and commissioning bodies in England – over 51,500 more people compared to a year ago which is an increase of 4.2%.

    Elsewhere, additional data shows there are more than 25,000 additional primary care staff as the government remains on course to reach its target of 26,000 more staff in primary care by March 2024.

    As of March 2023, 440 more full-time equivalent doctors were working in general practice compared to a year ago and they continue to deliver more face-to-face appointments.

    Health and Social Care Secretary, Steve Barclay, said:

    Today’s figures demonstrate the clear progress being made to train and recruit record numbers of staff across the NHS and in primary care. Cutting waiting lists is a key priority for this government and we are committed to ensuring we have the workforce in place to achieve that.

    We will soon be publishing a long term workforce plan focused on recruiting and retraining more staff – to help tackle the backlogs and improve patient care. We will also be publishing a plan outlining further support for primary care.

    The latest data also shows there are over 5,300 more doctors and over 12,300 more nurses working in the NHS compared to February 2022. Since 2010, there are now over 37,800 more doctors and over 53,700 more nurses.

    At the same time, almost two million more GP appointments were delivered in March 2023 compared to a year ago – that is 83,500 more appointments each working day.

    Last year, a record breaking 4,032 doctors accepted a place on GP training. Just as in hospitals, trainees deliver direct patient care while being safely supervised and support fully-qualified GPs, helping to ease workloads and increase capacity in general practice.

  • PRESS RELEASE : NHS set to save £7 billion thanks to world-leading medicine pricing scheme [April 2023]

    PRESS RELEASE : NHS set to save £7 billion thanks to world-leading medicine pricing scheme [April 2023]

    The press release issued by the Department of Health and Social Care on 24 April 2023.

    Voluntary scheme for branded medicines pricing and access (VPAS) delivers value for money to taxpayer and saves NHS billions, facilitating patient access to new lifesaving treatments and medicines, and supporting UK life sciences sector.

    The NHS will save £7 billion by the end of 2023 thanks to a 5-year agreement with the pharmaceutical industry, which ensures the NHS can continue to be one of the fastest health systems in the world to roll out innovative medicines.

    VPAS, the voluntary scheme for branded medicines pricing and access, was introduced in 2019 to keep the branded medicine bill affordable for the NHS by capping the growth of sales, while improving patient access to medicines by getting new medicines into use more quickly, and supporting our life sciences sector.

    Thanks to the scheme, thousands of NHS patients have benefitted from dozens of new treatments for conditions ranging from the most common cancers, to cutting edge gene therapy for ultra-rare disorders.

    Through VPAS, NHS England has:

    • delivered a world-leading rollout of cystic fibrosis triple therapy, which is crucial as the prevalence of cystic fibrosis in the UK is the second highest in Europe and third globally
    • secured first-in-Europe patient access for a number of new drugs, including a revolutionary lung cancer drug – sotorasib – and life-extending prostate cancer drug, darolutamide
    • negotiated commercial agreements to provide 3 new treatments, in less than 3 years, for children and adults with spinal muscular atrophy – the leading genetic cause of infant mortality
    • struck a series of national deals for HIV treatments and preventative drugs that will support England to meet an ambition to become the first country to end HIV transmissions before 2030

    Health Minister, Will Quince, said:

    Not only has VPAS delivered value for money for the taxpayer and saved the NHS billions of pounds, it has also saved people’s lives by supporting cancer patients and others with life-threatening conditions to have rapid access to new, life-saving and life-extending treatments.

    The scheme is vitally important as it keeps the branded medicine bill affordable for the NHS, and ensures the UK life sciences industry can earn the money it needs to fund research and development into new and improved medicine.

    The NHS buys medicines from pharmaceutical companies and is internationally competitive in the speed in adopting innovative medicines. Industry data shows there are 5 treatments available in England for every 4 in Europe, as well as almost a third more cancer drugs.

    VPAS has also helped NHS England to:

    • continue progress that keeps England on track to become the first country to eliminate hepatitis C ahead of the World Health Organization’s 2030 goal
    • fast-track more than 100 cancer drugs to NHS patients via the Cancer Drugs Fund
    • provide international leadership in the delivery of a subscription-style payment model for antibiotics to incentivise new development and help tackle antimicrobial resistance

    Chief Negotiations Advisor to the Department of Health and Social Care, Sir Hugh Taylor, said:

    The future VPAS scheme must continue to benefit the NHS and give its patients access to the best medicines, while supporting our life sciences sector.

    I’m looking forward to parties getting round the table to reach an agreement which not only benefits the NHS but will also encourage the pharmaceutical sector to continue investing in the UK.

    Negotiations for the successor to the current VPAS are expected to start in the spring, with Sir Hugh Taylor appointed by the government to oversee the negotiations. The successor scheme will come into force on 1 January 2024.

    NHS England’s Director for Commercial Medicines Negotiation, Rob Kettell, said:

    The NHS has a track record of using its commercial capabilities to secure world-leading access to life-changing new treatments for patients at the best value for the taxpayer, with recent industry data placing the UK in the top 3 fastest G20 countries to roll-out new medicines.

    This scheme has had a major impact for thousands of patients and their families, and ahead of negotiations for a new branded medicines agreement, the NHS is committed to working with government and industry to ensure that patients’ needs are at the forefront of these discussions.

  • PRESS RELEASE : Cancer survival rates improve by almost 10% [April 2023]

    PRESS RELEASE : Cancer survival rates improve by almost 10% [April 2023]

    The press release issued by the Department of Health and Social Care on 13 April 2023.

    Three in every four people survive their cancer the first year after being diagnosed, with rates of survival for some cancers even higher, according to figures out today.

    NHS England has published a one-year cancer survival index which looks at survival rates in 2020 compared to 2005. The index also breaks down the figures by types of cancer and where patients live.

    The index shows the overall first-year survival rate has risen 9% to 74.6%. The one-year breast cancer survival index is now about 97% and for bowel cancer the survival rate is now above 80%.

    These statistics focus on year-one survival, and support statistics released in February which revealed 5-year survival rates have also improved for most types of cancer, and child cancer survival rates were up to more than 86%.

    Cancer diagnosis and treatment remained a top priority throughout the pandemic, with more than 7.3 million urgent referrals and over 1.6 million people receiving cancer treatment between March 2020 and January 2023.

    Since the pandemic NHS England has continued to prioritise those waiting longer than 62 days for first treatment.

    We are making real progress in getting people the care they need more quickly and since July 2021 have opened 94 community diagnostic centres that have delivered 3.3 million checks, tests and scans.

    Health Minister Helen Whately said:

    These figures are highly encouraging and support those released earlier this year which show improved survival rates across almost all types of cancer. They are evidence of the great strides being made by the NHS, scientists and our incredible cancer charities.

    We are laser focused on fighting cancer on all fronts – prevention, diagnosis, treatment, research and funding – and have opened over 94 ‘one stop shops’ so people can have quicker access to tests, scans and checks. We are also taking a vaccine taskforce style approach to cancer research to develop new immune-based cancer therapies, including cancer vaccines, as well as producing a major conditions strategy.

    We know there is more to do and early diagnosis is crucial to improving survival rates even further. Our ambition is to diagnose 75% of cancer at an early stage by 2028 which will help save tens of thousands of lives for longer.

    NHS England’s early diagnosis strategy has 6 core elements including raising awareness of cancer symptoms and encouraging people to come forward as well as implementing targeted interventions for particular cancer types which are traditionally difficult to diagnose.

    More people are also taking up screening opportunities with 15 million invites in the past year.

    Background

    These statistics refer to survival rates from cancer specifically.

    The index compares the survival rate of people with cancer to the survival rate of the general population. The survival rate of people with cancer in the first year after diagnosis is 74.6% of the general population.

    These figures are based on net figures.

    Source: Cancer survival: index for sub-integrated care boards, 2005 to 2020

  • PRESS RELEASE : Smokers urged to swap cigarettes for vapes in world first scheme [April 2023]

    PRESS RELEASE : Smokers urged to swap cigarettes for vapes in world first scheme [April 2023]

    The press release issued by the Department of Health and Social Care on 11 April 2023.

    Pregnant women will also be offered financial incentives to help them quit as part of a sweeping package of measures to cut smoking rates in England.

    One million smokers will be encouraged to swap cigarettes for vapes under a pioneering new “swap to stop” scheme designed to improve the health of the nation and cut smoking rates.

    As part of the world-first national scheme, almost one in five of all smokers in England will be provided with a vape starter kit alongside behavioural support to help them quit the habit as part of a series of new measures to help the government meet its ambition of being smokefree by 2030 – reducing smoking rates to 5% or less. Local authorities will be invited to take part in the scheme later this year and will design a scheme which suits its needs, including deciding which populations to prioritise.

    In a speech today, Health Minister Neil O’Brien will also announce that following the success of local schemes, pregnant women will be offered financial incentives to help them stop smoking. This will involve offering vouchers, alongside behavioural support, to all pregnant women who smoke by the end of next year.

    The government will also consult on introducing mandatory cigarette pack inserts with positive messages and information to help people to quit smoking.

    Additionally, there will be a crackdown on illicit vape sales as part of measures to stop children and non-smokers take up the habit – which is growing in popularity among young people.

    Health Minister Neil O’Brien will say:

    Up to two out of three lifelong smokers will die from smoking. Cigarettes are the only product on sale which will kill you if used correctly.

    We will offer a million smokers new help to quit. We will be funding a new national ‘swap to stop’ scheme – the first of its kind in the world. We will work with councils and others to offer a million smokers across England a free vaping starter kit.

    The new policies will deliver the government’s three aims to help more adults quit smoking, stop children and non-smokers from taking up vaping, and using vaping as a tool for established adult smokers to quit.

    For those who quit, the risk of heart attack is halved after one year of quitting, ultimately halving the likelihood of ending up in a hospital bed or worse.

    Supporting more women to have a smokefree pregnancy will reduce the number of babies born underweight or underdeveloped with health problems requiring neonatal and ongoing care. It will also reduce the risk of miscarriage and stillbirth.

    Cutting smoking rates reduces the number of smoking-related illnesses needing to be treated, in turn reducing the pressure on the NHS, helping to deliver on our priority to cut NHS waiting lists.

    NHS figures for 2021 showed that 9% of 11- to 15-year-old children used e-cigarettes, up from 6% in 2018.

    In recognition of the sharp increase, Minister O’Brien will launch a Call for Evidence on youth vaping to identify opportunities to reduce the number of children accessing and using vape products – and explore where government can go further.

    Working with enforcement agencies and learning from the government’s work with Trading Standards on illicit tobacco, £3 million of new funding will also be provided to create a specialised ‘illicit vapes enforcement squad’ to enforce the rules on vaping and tackle illicit vapes and underage sales.

    As part of the measures, HMRC and Border Force will also be publishing an updated strategy this year to tackle illicit tobacco. It will lay out strategically how we continue to target, catch and punish those involved in the illicit tobacco market.

    Smoking prevalence in England in 2021 was 13% – the lowest on record thanks to measures such as doubling duty on cigarettes since 2010 and continued funding to local stop smoking services

    In 2021-22, £68 million of public health grant funded was spent on stop smoking services by local authorities and nearly 100,000 people quit with the support of a stop smoking service.

    In addition, £35 million has been committed to the NHS this year so that all smokers admitted to hospital will be offered NHS-funded tobacco treatment services.

    However, 5.4 million people in England smoke tobacco which remains the single biggest cause of preventable illness and death. Up to two out of three lifelong smokers will die from smoking and recent data shows one in four deaths from all cancers were estimated to be from smoking.

    Last year an independent smoking review led by Javed Khan proposed a range of measures to help people stub out the addiction, which has informed the measures set out today.

  • PRESS RELEASE : Crackdown on illegal sale of vapes [April 2023]

    PRESS RELEASE : Crackdown on illegal sale of vapes [April 2023]

    The press release issued by the Department of Health and Social Care on 9 April 2023.

    Bold new measures to combat rising levels of youth vaping expected to be announced.

    • A new ‘illicit vapes enforcement squad’ – backed by £3 million of government funding – to be formed to enforce rules on vaping and tackle illegal sales of vapes to under-18s
    • Call for Evidence also launched to identify opportunities to stop children vaping

    The government is expected to unveil tough new measures to combat the illegal sale of vapes to under-18s as part of its plans to reduce smoking and tackle youth vaping.

    In his speech at Policy Exchange on Tuesday 11 April, Health Minister Neil O’Brien is expected to announce a new ‘illicit vapes enforcement squad’ – backed by £3 million of government funding – to enforce the rules on vaping and tackle illicit vapes and underage sales.

    Working across the country, the enforcement squad led by Trading Standards will share knowledge and intelligence across regional networks and local authorities.

    It will undertake specific projects such as test purchasing in convenience stores and vape shops. It will also produce guidance to help build regulatory compliance, and will have the power to remove illegal products from shops and at our borders.

    The minister is also expected to announce the launch of a Call for Evidence to identify opportunities to reduce the number of children accessing and using vapes, while ensuring they remain available as a quit aid for adult smokers.

    It will explore topical issues such as the marketing and promotion of vapes and the environmental impact of disposable products.

    Health Minister Neil O’Brien said:

    Smoking kills, so our priority is to prevent people smoking, and support them to quit. We remain committed to our ambition to be smokefree by 2030.

    However, while vaping is a preferable alternative to smoking for adults, we are concerned about the rise in youth vaping, particularly the increasing use of disposable vaping products.

    The new illicit vapes enforcement squad will work across the country and clamp down on those businesses who sell vapes to children – which is illegal – and get them hooked on nicotine. Our Call for Evidence will also allow us to get a firm understanding of the steps we can take to reduce the number of children accessing and using vapes.

    Smoking prevalence in England in 2021 was 13.0%, the lowest on record, thanks to measures such as doubling duty on cigarettes since 2010 and continued funding to local stop smoking services. In 2021-22, £68 million of funding from the public health grant was spent on stop smoking services by local authorities, and nearly 100,000 people quit with the support of a stop smoking service.

    In addition, £35 million was committed to the NHS last year so that all smokers admitted to hospital will be offered NHS-funded tobacco treatment services.

  • PRESS RELEASE : Health and Social Care Secretary statement on vaccination of at-risk children aged 6 months to 4 years [April 2023]

    PRESS RELEASE : Health and Social Care Secretary statement on vaccination of at-risk children aged 6 months to 4 years [April 2023]

    The press release issued by the Department of Health and Social Care on 6 April 2023.

    Children aged 6 months to 4 years in a clinical risk group will be eligible for a Covid vaccine.

    Health and Social Care Secretary Steve Barclay said:

    Children are at very low risk of harm from Covid.

    However, there are a very small number of children with health conditions which make them particularly vulnerable, and for those children we want to give parents the choice as to whether they wish to vaccinate their at risk child or not.

    I have accepted advice from the Joint Committee on Vaccination and Immunisation on vaccinating children aged from 6 months to 4 years who are in a clinical risk group. It is a parental decision, and this advice is simply to enable parents of children with medical conditions to choose if they wish to have the protection.

  • PRESS RELEASE : Record doctors and nurses working in the NHS helping to cut waiting lists [April 2023]

    PRESS RELEASE : Record doctors and nurses working in the NHS helping to cut waiting lists [April 2023]

    The press release issued by the Department of Health and Social Care on 6 April 2023.

    Latest data shows there are more doctors, nurses and staff than ever before working in the NHS.

    • Government on track to deliver on commitment for 50,000 more nurses by 2024, with over 41,000 more nurses compared to September 2019
    • New pension rules also come into force today to support senior clinicians to continue working in the NHS for longer

    There are record number of doctors and nurses working in the NHS in England helping to deliver extra appointments, speed up diagnoses and cut waiting lists, according to the latest stats.

    Data published today by NHS Digital shows in January 2023 there were almost 1.27 million full-time equivalent staff working in NHS trusts and commissioning bodies in England – over 48,700 more people compared to a year ago, an increase of 4%.

    The latest data also shows there were over 5,100 more doctors and over 11,800 more nurses working in the NHS compared to January 2022.

    Since 2010, there are now over 37,700 more doctors and over 52,400 more nurses working in the NHS. The government is also on track to deliver on its commitment for 50,000 more nurses by 2024, with over 41,000 more nurses compared to September 2019.

    Separately, reforms to public sector pensions announced at Budget come into force today which will increase the annual tax-free pension allowance from £40,000 to £60,000 and remove the lifetime allowance charge. These changes will ensure doctors are not disincentivised from remaining in their NHS roles or taking on extra hours, meaning more expertise will be retained so we can continue treating patients and helping to cut waiting lists.

    This is alongside wider changes to the NHS Pension Scheme to make retirement more flexible and support staff to remain in work for longer. These changes include allowing retired and partially retired staff to return to work or increase their working hours without having payments to their pension reduced or suspended, fixing the unintended impacts of inflation so senior clinicians are not taxed more than necessary and ensuring staff can continue to access the scheme when working in Primary Care Networks.

    Around 22,000 senior NHS clinicians could exceed the previous £40,000 annual allowance in 2023/24 and around 31,000 clinicians have reached at least 75% of the £1.073 million lifetime allowance.

    These changes will mean more senior clinicians will be incentivised to stay in the workforce and work as many hours as they want, helping boost the workforce as the NHS continues to tackle the backlogs.

    Health and Social Care Secretary, Steve Barclay, said:

    It’s crucial we have a sustainable workforce as we build a stronger, healthier NHS for the long term with patients at its centre.

    We are making progress in training and recruiting a record number of staff – with over 48,700 more compared to a year ago and the NHS will soon publish a workforce plan focused on recruiting and retaining more staff.

    Today’s pension changes will also help boost numbers of senior clinicians – so we can continue delivering high quality care for patients.

    NHS England will publish a comprehensive workforce strategy this year to help recruit and retain more staff, with independently verified forecasts for the number of doctors, nurses and other professionals that will be needed in five, 10 and 15 years’ time.